Genmab — December 2017
-
Lægemidler til knoglemarvskræft solgte i 2016 for 13 mia. dollar og ventes at nå 22 mia. dollar i 2022, ifølge Evaluate Pharma. http://borsen.dk/nyheder/avisen/artikel/11/186296/artikel.html#cxrecs_s
-
det er godt nok flere år siden, den har så dårligt kærende 2 dage foer ASH
-
A/B har smidt for 52 mio.
i dag indtil nu -
if you are really really bored, JNJ at Citi this evening https://www.veracast.com/webcasts/citigroup/healthcare2017/38207174881.cfm I think that is 18.35 our time
-
Godt man har Pandora...shorterne er ved at trække sig

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind